WallStreetZenWallStreetZen

NASDAQ: BMGL
Basel Medical Group Revenue

OverviewEarningsRevenue
DividendOwnership
Basel Medical Group revenue was N/A for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, BMGL annual revenue was $7.4M, with -23.6% growth year-over-year.

BMGL revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when BMGL announces revenue.

BMGL Revenue History By Year

BMGL Yearly RevenueBMGL RevenueBMGL ChangeBMGL Revenue Growth
2024-06-30$7.42M-$2.29M-23.55%
2023-06-30$9.70MN/AN/A

1 of 1

Basel Medical Group Revenue FAQ

What was Basel Medical Group's annual revenue growth in the past year?

As of Q3 2025, Basel Medical Group's revenue has grown null year over year. Basel Medical Group's revenue in the past year totaled N/A.

How much does Basel Medical Group make in a year?

Basel Medical Group's revenue by year for the past one years is:
  • Basel Medical Group's revenue for the twelve months ending Jun 30, 2024 was $7.42 million, a 23.55% decrease year over year.

What was Basel Medical Group's revenue in 2024?

Basel Medical Group's annual revenue for the twelve months ending Jun 30, 2024 was $7.42 million, a 23.55% decrease year over year.

How much does Basel Medical Group make in a day?

Based on Basel Medical Group annual revenue for the past one years, BMGL makes an average of $20,319.34 per day.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.